Personalization of Induction Therapy for Pediatric AML to Ara-C plus Dauno plus Etoposide (ADE) or Clofarabine plus Ara-C According to a Polygenic Ara-C SNP Score-ACS10

被引：0
|
作者：
Lamba, Jatinder K. [1 ,2 ]
Marrero, Richard J. [3 ]
Elsayed, Abdelrahman H. [3 ]
Cao, Xueyuan [4 ]
Wu, Huiyun [5 ]
Inaba, Hiroto [6 ]
Raimondi, Susana C. [7 ]
Pui, Ching-Hon [8 ]
Ribeiro, Raul C. [9 ]
Rubnitz, Jeffrey E. [6 ]
Pounds, Stanley B. [5 ]
机构：
[1] Univ Florida, Coll Pharm Pharmacotherapy & Translat Re, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA
[2] UF Hlth Canc Ctr, Gainesville, FL USA
[3] Univ Florida, Dept Pharmacotherapy & Translat Res, Coll Pharm, Gainesville, FL USA
[4] Univ Tennessee, Dept Hlth Promot & Dis Prevent, Hlth Sci Ctr, Memphis, TN USA
[5] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN USA
[6] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA
[7] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA
[8] St Jude Childrens Rsch Hosp, Dept Oncol, Memphis, TN USA
[9] 5t Jude Childrens Res Hosp, Memphis, TN USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159657
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1039 / 1040
页数：2
相关论文
共 50 条
  • [21] LOW-DOSE ARA-C AS AN ALTERNATIVE THERAPY FOR OLDER PATIENTS WITH AML
    HEYLL, A
    AUL, C
    HEYLL, U
    FISCHER, JT
    SCHNEIDER, W
    BLUT, 1985, 51 (03): : 163 - 163
  • [22] Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein
    Cecilia H. Fu
    Sagrario Martin-Aragon
    Kenneth I. Weinberg
    Veronica C. Ardi
    Peter V. Danenberg
    Vassilios I. Avramis
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 123 - 133
  • [23] Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein
    Fu, CH
    Martin-Aragon, S
    Weinberg, KI
    Ardi, VC
    Danenberg, PV
    Avramis, VI
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (02) : 123 - 133
  • [24] A 5-Gene Ara-C, Daunorubicin and Etoposide (ADE) Drug Response Score As a Prognostic Tool to Predict AML Treatment Outcome
    Elsayed, Abdelrahman H.
    Wu, Huiyun
    Cao, Xueyuan
    Raimondi, Susana C.
    Downing, James R.
    Ribeiro, Raul
    Gruber, Tanja A.
    Ries, Rhonda E.
    Meshinchi, Soheil
    Rubnitz, Jeffrey
    Pounds, Stanley
    Lamba, Jatinder K.
    BLOOD, 2019, 134
  • [25] Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients
    Russo, D
    Malagola, M
    Vivo, A
    Fiacchini, M
    Martinelli, G
    Piccaluga, PP
    Damiani, D
    Candoni, A
    Michielutti, A
    Castelli, M
    Testoni, N
    Ottaviani, E
    Rondoni, M
    Pricolo, G
    Mazza, P
    Zuffa, E
    Zaccaria, A
    Raspadori, D
    Bocchia, M
    Lauria, F
    Bonini, A
    Avanzini, P
    Gugliotta, L
    Visani, G
    Fanin, R
    Baccarani, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (02) : 172 - 179
  • [26] Ara-CTP-SNP-Score (ACSS) Created from SNP within the Cytarabine Metabolic Pathway Correlates with Response to Ara-C Induction Therapy in Elderly Patients with AML: A Pilot Study
    Desai, Ruchi
    Lamba, Jatindar
    Lancet, Jeffrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S201 - S201
  • [27] Carboplatin (CBDCA) plus cytarabine (ARA-C) in the treatment of high-risk acute myeloblastic leukemia
    Larrea, L
    Martin, G
    Sanz, GF
    Martinez, JA
    Arnao, M
    Jarque, I
    Jimenez, C
    Sanz, MA
    BLOOD, 1996, 88 (10) : 856 - 856
  • [28] Retrospective analysis of clofarabine/Ara-C salvage chemotherapy preceding allogeneic stem cell transplantation for AML
    Loeffler, C.
    Kapp, M.
    Grigoleit, G. U.
    Mielke, S.
    Loeffler, J.
    Einsele, H.
    Stuhler, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S277 - S277
  • [29] Comprehensive Ara-C SNP score predicts leukemic cell intracellular ara-CTP levels in pediatric acute myeloid leukemia patients
    Elsayed, Abdelrahman H.
    Cao, Xueyuan
    Crews, Kristine R.
    Gandhi, Varsha
    Plunkett, William
    Rubnitz, Jeffrey E.
    Ribeiro, Raul C.
    Pounds, Stanley B.
    Lamba, Jatinder K.
    PHARMACOGENOMICS, 2018, 19 (14) : 1101 - 1110
  • [30] PROLONGED SURVIVAL OF PATIENTS WITH ACUTE NON-LYMPHOBLASTIC LEUKEMIA FOLLOWING ARABINOSYL CYTOSINE (ARA-C), VINCRISTINE (VCR) AND PREDNISONE (PRED) INDUCTION AND ARA-C MAINTENANCE THERAPY
    GROZEA, PN
    BOTTOMLEY, RH
    TU, H
    CONDIT, PT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 91 - +
12345